How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD?

Primary Care Respiratory Journal

Volumn 21, Issue 2, 2012, Pages 202-207

  Boer, Lonneke M ^a   Asijee, Guus M ^b,c   van Schayck, Onno C P ^c   Schermer, Tjard R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Dyspnoea scales; Functional capacity; Quantitative research

Indexed keywords

ACTIVITY BASED DYSPNEA SCALE; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BASELINE DYSPNEA INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COPD QUESTIONNARIE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPNEA; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; INCREMENTAL SHUTTLE WALK TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; OXYGEN COST DIAGRAM; PRACTICE GUIDELINE; QUESTIONNAIRE; SAINT GEORGES RESPIRATORY QUESTIONNAIRE; STATISTICAL SIGNIFICANCE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 84862663394     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00031     Document Type: Article

References (34)

1. Global strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. http://www.goldcopd.org/ (accessed 10 Nov 2011).
2. 1. Respir Med 2008;102(Suppl 1):S27-35. http://dx.doi.org/10.1016/ S0954-6111(08)70005-2
3. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997;156:1032-9. http://ajrccm.atsjournals.org/cgi/ content/full/156/4/1032
4. Cazzola M, Hanania NA, Jones PW, et al. It's about time-directing our attention toward modifying the course of COPD. Respir Med 2008;102(Suppl 1):S37-48. http://dx.doi.org/10.1016/S0954-6111(08)70006-4
5. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167(4):544-9. http://dx.doi.org/10.1164/rccm.200206-583OC
6. Casanova C, Cote C, Marin JM, et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008;134(4):746-52. http://dx.doi.org/10.1378/chest.08-0520
7. Celli BR. Predictors of mortality in COPD. Respir Med 2010;104(6):773-9. http://dx.doi.org/10.1016/j.rmed.2009.12.017
8. Dolan S, Varkey B. Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005;11(2):149-52. http://dx.doi.org/10.1097/ 01.mcp.0000153548.36054.8f
9. Spruit MA, Polkey MI, Celli B, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012;13(3):291-7. http://dx.doi.org/10.1016%2Fj.jamda.2011.06.009
10. Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007;29(1):185-209. http://dx.doi.org/10.1183/09031936.00046906
11. Haughney J, Gruffydd-Jones K. Patient-centred outcomes in primary care management of COPD-what do recent clinical trial data tell us? Prim Care Respir J 2004;13(4):185-97. http://dx.doi.org/10.1016/j.pcrj.2004.06.006
12. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257-66. http://dx.doi.org/10.1136/bmj.2.5147.257
13. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Clinical Guideline Centre, 2010. http://guidance.nice.org.uk/ (accessed 10 Nov 2011).
14. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 2007;14(Suppl B):5B-32B. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2806792/
15. Smeele IJM, van Weel C, van Schayck CP, et al. NHG-Standaard COPD. Second Revision. Huisarts Wet 2007;50:362-79.
16. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7(4):725-9. http://dx.doi.org/10.1183/09031936.94.07040725
17. Hoogendoorn M, Rutten-van Molken MP, Hoogenveen RT, et al. A dynamic population model of disease progression in COPD. Eur Respir J 2005;26(2):223-33. http://dx.doi.org/10.1183/09031936.05.00122004
18. Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. Arch Intern Med 2005;165(19):2286-92. http://dx.doi.org/10.1001/archinte.165.19.2286
19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
20. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47(12):1019-24. http://dx.doi.org/10.1136/thx.47.12.1019
21. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581-6. http://dx.doi.org/10.1136/thx.54.7.581
22. McKenzie DK, Abramson M, Crockett AJ, et al. on behalf of The Australian Lung Foundation. The COPD-X Plan: Australian and New Zealand. Guidelines for the management of chronic obstructive pulmonary disease 2011. http://www.copdx.org.au/ (accessed 22 Dec 2011).
23. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85(6):751-8. http://dx.doi.org/10.1378/chest.85.6.751
24. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 1978;2:241-3. http://dx.doi.org/10.1136/bmj.2.6132.241
25. Van Der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1(1):13. http://dx.doi.org/10.1186/1477-7525-1-13
26. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321-7.
27. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-12. http://dx.doi.org/10.1056/NEJMoa021322
28. Foglio K, Carone M, Pagani M, Bianchi L, Jones PW, Ambrosino N. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Respir Med 2000;94(3):256-63. http://dx.doi.org/10.1053/ rmed.1999.0734
29. Kocks JW, Asijee GM, Tsiligianni IG, Kerstjens HA, van der Molen T. Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J 2011;20(3):269-75. http://dx.doi.org/10.4104/ pcrj.2011.00031
30. Vercoulen JH, Daudey L, Molema J, et al. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med 2008;15(4):263-79. http://dx.doi.org/10.1080/10705500802365474
31. Taylor S, Frost H, Taylor A, Barker K. Reliability and responsiveness of the shuttle walking test in patients with chronic low back pain. Physiother Res Int 2001;6(3):170-8. http://dx.doi.org/10.1002/pri.225
32. Singh SJ, Jones PW, Evans R, Morgan MD. Minimum clinically important improvement for the incremental shuttle walking test. Thorax 2008;63(9):775-7. http://dx.doi.org/10.1136/thx.2007.081208
33. Geijer RM, Sachs AP, Verheij TJ, Kerstjens HA, Kuyvenhoven MM, Hoes AW. Quality of life in smokers: focus on functional limitations rather than on lung function? Br J Gen Pract 2007;57(539):477-82.
34. Tirimanna PR, van Schayck CP, den Otter JJ, et al. Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? Br J Gen Pract 1996;46(406):277-81.